6.73
-0.42
(-5.92%)
At close: January 10 at 5:36:02 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DRUTZ DAVID J Director | Sale | Aug 19, 2024 | -- |
| EISENSTADT RICHARD I Chief Financial Officer | Stock Award(Grant) | Jan 31, 2024 | 45,012 |
| GARG VIPIN K. Chief Executive Officer | Conversion of Exercise of derivative security | Feb 2, 2024 | 292,028 |
| HARRIS MATTHEW SCOTT Officer | Stock Award(Grant) | Jul 31, 2024 | 55,119 |
| JORDT RAYMOND M Officer | Conversion of Exercise of derivative security | Dec 31, 2024 | 21,550 |
| ROBERTS M SCOT Officer | Stock Award(Grant) | Jul 31, 2024 | 43,325 |
| SHUTTERLY ANDREW Chief Financial Officer | Stock Award(Grant) | Jul 31, 2024 | 11,372 |
Related Tickers
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
7IZ.MU Ziccum AB
0.0298
-29.72%
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
41X.F Ardelyx, Inc.
5.12
+0.16%
4AJ0.SG Alk-Abello A/S
19.46
+0.46%
CXF.F Chimerix, Inc.
3.1350
-6.00%
BLE.BE bluebird bio Inc
0.3708
-3.01%
RGO.HA Regeneron Pharmaceuticals Inc
683.60
-2.73%
XRP2.F Silence Therapeutics plc
5.95
+0.85%